Activity of human p450 2D6 in biphasic solvent systems

被引:6
|
作者
Zhao, Jin [1 ]
Tan, Elaine [1 ]
Ferras, Julian [1 ]
Auclair, Karine [1 ]
机构
[1] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada
关键词
biocatalyst; biphasic; CYP; hydroxylation; organic solvent;
D O I
10.1002/bit.21449
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Several limitations have restricted the use of P450 enzymes in synthesis, including the narrow substrate specificity of some P450 isoforms, the need for a redox partner and an expensive cofactor, incompatibility with organic solvents, and poor stability. We previously demonstrated that the natural redox partner and cofactor of the promiscuous P450s 3A4 and 2D6 can be efficiently substituted with some cheap hydrogen peroxide donors or organic peroxides. We report here that P450 2D6 maintains as much as 76% of its activity when used in buffer/organic emulsions. Product formation in biphasic solvent systems is comparable whether the natural redox partner and cofactor are used, or a surrogate. As reported for the enzymes, a correlation is observed between the logP and suitability of a solvent for enzymatic activity. Moreover, the utility of our system was established by demonstrating the transformation of a novel hydrophobic substrate, not modified by P450 2D6 in the absence of organic solvent.
引用
收藏
页码:508 / 513
页数:6
相关论文
共 50 条
  • [1] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [2] QSAR models for P450 (2D6) substrate activity
    Ringsted, Tine
    Nikolov, N.
    Jensen, G. E.
    Wedebye, E. B.
    Niemela, J.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2009, 20 (3-4) : 309 - 325
  • [3] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [4] Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate
    McConnachie, L
    Bodor, M
    Kowdley, K
    Levy, A
    Tung, B
    Thummel, K
    Phillips, B
    Bajpai, M
    Chi, V
    Esmay, JD
    Shen, DA
    Ho, RJY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (04) : 282 - 297
  • [5] A refilled substrate model for human cytochrome P450 2D6
    deGroot, MJ
    Bijloo, GJ
    Martens, BJ
    vanAcker, FAA
    Vermeulen, NPE
    CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) : 41 - 48
  • [6] Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen
    Dong, HJ
    Haining, RL
    Thummel, KE
    Rettie, AE
    Nelson, SD
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (12) : 1397 - 1400
  • [7] Inhibitory monoclonal antibodies to human cytochrome P450 2D6
    Krausz, KW
    Yang, TJ
    Gonzalez, FJ
    Shou, MG
    Gelboin, HV
    BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) : 15 - 17
  • [8] Inhibition of human cytochrome P450 2D6 by schering 66712
    Butler, Brendan Francis
    Palamanda, Jairam
    Nomeir, Amin A.
    Guengerich, F. Peter
    Furge, Laura Lowe
    FASEB JOURNAL, 2007, 21 (05): : A670 - A670
  • [9] Allosteric effects of cytochrome P450 reductase on cytochrome P450 2D6
    Roberts, GCK
    Modi, S
    Gilham, DE
    Sutcliffe, MJ
    Lian, LY
    Primrose, WU
    Wolf, CR
    FASEB JOURNAL, 1997, 11 (09): : A789 - A789
  • [10] Cytochrome P450 2D6 as a Model Antigen
    Christen, Urs
    Holdener, Martin
    Hintermann, Edith
    DIGESTIVE DISEASES, 2010, 28 (01) : 80 - 85